보고서 요약(국문)

시장 개요
글로벌 신약 개발 서비스 시장은 2022년 137억 달러 규모에 달했으며, 2030년까지 399억 달러에 이르러 높은 성장세를 보일 것으로 예상됩니다. 글로벌 신약 개발 시장은 예측 기간(2023~2030년) 동안 연평균 14.8%의 성장률을 기록할 것으로 전망됩니다.
글로벌 신약 개발 서비스 시장은 최근 몇 년간 여러 주요 요인에 힘입어 눈부신 성장과 발전을 보여왔습니다. 암, 신경계 질환, 심혈관 질환과 같은 만성 질환의 유병률 증가로 인해 새로운 의약품 및 치료법에 대한 수요가 급증했습니다. 이에 따라 제약 회사들은 신약 개발 서비스를 전문 임상시험수탁기관(CRO)에 아웃소싱하는 사례가 늘어났습니다.
글로벌 신약 개발 서비스 시장의 주요 성장 동력은 암과 같은 만성 질환의 유병률 증가로, 첨단 의약품 및 치료법에 대한 수요가 크게 증가한 데 있습니다. 예를 들어, 폐암 발병률 증가로 인해 상당한 약물 연구 노력이 촉발되었고, 그 결과 오시머티닙(osimertinib)과 크리조티닙(crizotinib)과 같은 티로신 키나제 억제제(TKI)와 같은 표적 치료제가 개발되었습니다.
시장 동향
기술 및 연구 도구의 발전이 글로벌 신약 개발 서비스 시장의 성장을 견인하고 있습니다.
특히 3D 바이오프린팅 분야의 기술 및 연구 도구 발전은 글로벌 신약 개발 서비스 시장의 성장을 촉진하고 있습니다. 예를 들어, 2023년 1월, Molecular Devices와 Advanced Solutions Life Sciences는 신약 개발을 위한 3D 생물학 자동화 도구 개발을 위해 협력 관계를 맺었습니다. 이 협력의 일환으로 Molecular Devices는 Advanced Solutions의 BioAssemblyBot 400(BAB 400) 바이오프린팅 플랫폼을 판매할 예정입니다.
BAB 400은 생명 과학자들이 더 높은 처리량과 정밀도로 3D 모델 시스템을 제작할 수 있도록 하는 6축 지능형 로봇 팔입니다. 이 방법은 바이오프린팅 공정을 자동화하여 수동 공정과 관련된 일반적인 문제를 해결함으로써 신약 개발의 생산성과 신뢰성을 향상시킵니다. 이번 협력은 최첨단 바이오프린팅 기술이 신약 개발 서비스 시장에 도입되어 해당 분야의 혁신을 더욱 가속화할 것임을 의미합니다.
고령 인구 증가가 세계 신약 개발 서비스 시장 성장을 견인
세계 신약 개발 서비스 시장은 고령 인구 증가에 힘입어 성장할 것으로 예상됩니다. 고령 인구는 만성 질환 및 노화 관련 질환 발병률이 높아 새로운 의약품 및 치료법에 대한 수요가 증가하고 있습니다. 이에 따라 제약 회사와 연구 기관은 고령자의 특별한 의료 요구를 충족하는 의약품 개발에 집중하고 있습니다.
예를 들어, 세계보건기구(WHO)의 2022년 보고서에 따르면 2030년에는 전 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상됩니다. 이 기간 동안 60세 이상 세계 인구는 2020년 10억 명에서 14억 명으로 증가할 것으로 예상됩니다. 2050년에는 60세 이상 인구가 세 배 이상 증가하여 21억 명에 육박할 것입니다. 따라서 이러한 요인들로 인해 전 세계 신약 개발 서비스 시장은 예측 기간 동안 성장세를 보일 것으로 예상됩니다.
신약 개발 및 동물 사용에 대한 엄격한 규제가 전 세계 신약 개발 서비스 시장 성장을 저해하고 있습니다.
신약 개발에서 동물 사용을 제한하는 엄격한 규제는 연구 활동에 어려움을 초래합니다. 쥐, 생쥐, 물고기, 양서류, 파충류와 같은 동물들이 연구에 일반적으로 사용되지만, 윤리적 문제로 인해 각국은 동물 안전 및 사용에 관한 법률을 제정했습니다. 이로 인해 기업들은 동물 사용을 줄이기 위한 대체 방법을 모색하게 되었습니다. 그러나 이러한 측면은 예측 기간 동안 전 세계 신약 개발 서비스 시장의 성장을 저해할 것으로 예상됩니다.

COVID-19 영향 분석
전 세계 신약 개발 서비스 시장은 COVID-19 팬데믹으로 인해 긍정적인 영향을 받았습니다. 팬데믹으로 인해 정부의 신약 개발 연구 자금 지원과 제약 회사의 투자가 증가했습니다. 그 결과, 표적 식별, 선도 물질 최적화 및 전임상 개발 분야에서 신약 개발 서비스에 대한 수요가 증가했습니다.
또한, 팬데믹은 신약 연구 수행 방식에 여러 가지 변화를 가져왔습니다. 예를 들어, 신약 개발에 인공지능과 머신러닝을 활용하는 데 더 큰 비중이 두어졌습니다. 이러한 기술은 신약 개발 속도를 높이는 동시에 개발 비용을 절감하는 데 도움이 될 수 있기 때문입니다.
러시아-우크라이나 분쟁 분석
러시아와 우크라이나 간의 전쟁은 전 세계 신약 개발 서비스 산업에 상당한 장애물을 초래했습니다. 이러한 문제에는 에너지 가격 상승 및 공급망 차질, 연구소 대피 또는 이전으로 인한 연구 지연, 기업의 데이터 및 지적 재산에 대한 사이버 공격 위험 증가 등이 포함됩니다. 결과적으로, 시장은 가까운 미래에 둔화될 것으로 예상됩니다.

그러나 신약 수요가 높은 수준을 유지하고 있기 때문에 장기적으로는 시장이 회복될 것으로 예상됩니다. 전쟁은 심각한 결과를 초래했지만, 우크라이나에서 만연한 질병에 대한 연구를 촉진하고 제약 회사 간의 협력을 강화하여 잠재적으로 새로운 치료법 개발로 이어질 수 있었습니다. 따라서 전쟁이 시장에 미치는 전반적인 영향은 도전과 기회가 복합적으로 작용하는 것으로 볼 수 있습니다.
세분화 분석
글로벌 신약 개발 서비스 시장은 프로세스 유형, 서비스 유형, 애플리케이션 유형, 최종 사용자 및 지역별로 세분화됩니다.
제약 및 생명공학 기업 부문은 예측 기간 동안 글로벌 신약 개발 서비스 시장에서 지배적인 위치를 차지할 것으로 예상됩니다.
제약 및 생명공학 기업 부문은 2022년 신약 개발 서비스 시장에서 약 34.8%의 시장 점유율을 차지하며 가장 높은 시장 점유율을 기록했습니다. 새로운 치료법의 연구 및 상용화를 선도하는 제약 및 생명공학 기업들은 글로벌 신약 개발 서비스 산업을 주도할 것으로 예상됩니다. 이들의 연구 개발에 대한 상당한 투자와 임상시험수탁기관(CRO)과의 협력은 신약 개발 서비스 시장의 수요를 촉진할 것입니다.

예를 들어, 생명과학 산업에 첨단 분석, 기술 솔루션 및 임상 연구 서비스를 제공하는 세계적인 선도 기업인 IQVIA는 2022년 11월 이스라엘 최대 의료 서비스 기관인 Clalit과 장기 파트너십을 체결하고 이스라엘 최초의 프라임 사이트(Prime Site)를 개설한다고 발표했습니다. 따라서 위와 같은 요인들로 인해 해당 시장 부문은 예측 기간 동안 글로벌 신약 개발 서비스 시장에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
지역 분석
북미, 글로벌 신약 개발 서비스 시장에서 주도적인 위치 차지
북미는 만성 질환의 증가, 제약 및 생명공학 기업의 강력한 입지, 연구 개발 활동에 대한 상당한 투자, 신약 개발을 지원하는 정부 정책 등 여러 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.6%를 차지할 것으로 예상됩니다.
심혈관 질환, 암, 당뇨병, 호흡기 질환과 같은 만성 질환은 북미 지역에서 상당한 부담을 주고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)의 2022년 보고서에 따르면, 만성 질환은 미국에서만 10명 중 6명에게 영향을 미치며, 사망 및 장애의 주요 원인일 뿐만 아니라 연간 4조 1천억 달러에 달하는 미국의 막대한 의료비 지출의 주요 원인이기도 합니다. 따라서 이러한 요인들로 인해 시장은 예측 기간 동안 성장세를 보일 것으로 예상됩니다.
경쟁 환경
이 시장의 주요 글로벌 기업으로는 Piramal Pharma Solutions, Biopta, Charles River Laboratories International, Domainex, Evotec AG, Albany Molecular Research Inc., GenScript, Pharmaceutical Product Development, LLC (PPD), WuXi AppTec, Merck & Co., Inc. 등이 있습니다.

보고서 구매 이유

• 프로세스 유형, 서비스 유형, 애플리케이션 유형, 최종 사용자 및 지역별 글로벌 신약 개발 서비스 시장 세분화를 시각화하고 주요 기업 및 사업자를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 부문을 포함한 신약 개발 서비스 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 신약 개발 서비스 시장 보고서는 약 49개의 표, 53개의 그림, 195페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Drug Discovery Services Market reached US$ 13.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 39.9 billion by 2030. The global drug discovery market is expected to exhibit a CAGR of 14.8% during the forecast period (2023-2030).
The global drug discovery services market has shown tremendous growth and development in recent years, owing to a number of major developments. The rising prevalence of chronic diseases such as cancer, neurological disorders, and cardiovascular disease has produced a strong demand for novel medications and therapies. This has resulted in an increase in pharmaceutical companies outsourcing drug development services to specialized contract research organizations (CROs).
The global drug discovery services market is being fueled primarily by the rising prevalence of chronic diseases such as cancer, which has created a significant need for advanced medication and therapies. For instance, the increasing prevalence of lung cancer has prompted significant drug research efforts, resulting in the development of targeted treatments such as tyrosine kinase inhibitors (TKIs) such as osimertinib and crizotinib.
Market Dynamics
The Advancements in Technology and Research Tools is Propelling the Growth of the Global Drug Discovery Services Market
Technological and research tool advancements, notably in the realm of 3D bioprinting, are propelling the global drug discovery services market. For instance, in January 2023, Molecular Devices and Advanced Solutions Life Sciences have formed a collaboration to develop 3D biology automation tools for drug discovery. As part of this collaboration, Molecular Devices will market Advanced Solutions' BioAssemblyBot 400 (BAB 400) bioprinting platform.
BAB 400 is a six-axis intelligent robotic arm that allows life scientists to create 3D model systems with greater throughput and precision. This method eliminates common issues associated with manual processes by automating the bioprinting process, resulting in increased productivity and dependability in drug discovery. This collaboration signifies the incorporation of cutting-edge bioprinting technology into the drug discovery services market, propelling innovations in the sector even further.
The Increasing Geriatric Population is Driving the Growth of the Global Drug Discovery Services Market
The global drug discovery services market is likely to be driven by the expanding elderly population. The elderly population has a greater incidence of chronic diseases and age-related ailments, which increases the demand for novel medications and therapies. As a result, pharmaceutical companies and research institutions are concentrating their efforts on developing medications that address the special healthcare needs of the aged.
For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. In 2050, the number of persons aged 60 and up will more than treble, approaching 2.1 billion. Hence, owing to the above factors, the global drug discovery services market is expected to drive over the forecast period.
Stringent Regulations Governing Drug Discovery and Animal Usage is Hampering the Growth of the Global Drug Discovery Services Market
The strict limits limiting the use of animals in drug development present difficulties for research practices. Animals such as mice, rats, fish, amphibians, and reptiles are routinely used in research, but ethical concerns have pushed nations to enact animal safety and use legislation. This has prompted businesses to use alternate methods to reduce the use of animals. This aspect, however, is projected to impede the growth of the worldwide drug discovery services market during the forecast period.
COVID-19 Impact Analysis
The global drug discovery services market has been significantly impacted by the COVID-19 pandemic in a positive way. The epidemic has increased government financing for drug development research, as well as pharmaceutical company investment. As a result, demand for drug discovery services has increased, notably in the areas of target identification, lead optimization, and preclinical development.
Furthermore, the pandemic has caused a number of modifications in the way drug research is conducted. For example, a larger emphasis has been placed on the use of artificial intelligence and machine learning in drug discovery. This is because these technologies can help to speed drug discovery while also lowering drug development costs
Russia-Ukraine Conflict Analysis
The war between Russia and Ukraine has posed considerable obstacles to the global drug discovery services industry. These issues include growing energy prices and supply chain disruptions, research delays caused by lab evacuation or relocation, and an increased risk of cyberattacks on organizations' data and intellectual property. As a result, the market is expected to slow down in the near future.
However, the market is projected to rebound in the long run as demand for new drugs remains high. Despite its severe consequences, the war has promoted research into diseases prevalent in Ukraine and fostered collaboration among drug discovery companies, potentially leading to novel treatments. Thus, the overall impact of the war on the market is a mix of challenges and opportunities.
Segment Analysis
The global drug discovery services market is segmented based on process type, service type, application type, end user, and region.
The Pharmaceutical & Biotechnology companies Segment is expected to hold a Dominant Position for the Global Drug Discovery Services Market over the Forecast Period
The pharmaceutical & Biotechnology companies segment accounted for the highest market share accounting for approximately 34.8% of the drug discovery services market in 2022. Pharmaceutical & biotech companies, which are at the forefront of the research and commercialization of novel treatments, are positioned to dominate the global drug discovery services industry. Their significant investments in R&D, and collaborations with CROs will fuel demand for drug discovery services market.
For instance in November 2022, IQVIA, a leading global provider of advanced analytics, technological solutions, and clinical research services to the life sciences industry, announced today a long-term partnership with Clalit, Israel's largest health services organization, to open the country's first Prime Site. Thus, owing to the above factors, the market segment is expected to hold the largest market share for global drug discovery services market over the forecast period.
Geographical Analysis
North America holds a Dominant Position in the Global Drug Discovery Services Market
North America is estimated to hold around 38.6% of the total market share throughout the forecast period, owing to the rising prevalence chronic diseases, strong presence of pharmaceutical and biotechnology companies, significant investment in R&D activities, and favorable government initiatives supporting drug discovery and development are some of the key are the factors expected to drive the drug discovery services market in North America region over the forecast period.
Chronic diseases, such as cardiovascular disease, cancer, diabetes, and respiratory disorders, are a significant burden in North America. For instance, according to Centers for Disease Control and Prevention 2022 report, chronic diseases impact 6 out of 10 persons in the U.S. alone, and they are not only primary causes of mortality and disability, but also key contributors to the country's astounding yearly healthcare expenses of $4.1 trillion. Hence, owing to the above factors, the market is expected to drive over the forecast period.
Competitive Landscape
The major global players in the market include Piramal Pharma Solutions, Biopta, Charles River Laboratories International, Domainex, Evotec AG, Albany Molecular Research Inc., GenScript, Pharmaceutical Product Development, LLC (PPD), WuXi AppTec, and Merck & Co., Inc., among others.
Why Purchase the Report?
• To visualize the global drug discovery services market segmentation based on the process type, service type, application type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of drug discovery services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global drug discovery services market report would provide approximately 49 tables, 53 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Process Type
3.2. Snippet by Service Type
3.3. Snippet by Application Type
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Rising Prevalence of Chronic Diseases
4.1.1.2. The Increasing R&D Expenditure
4.1.2. Restraints
4.1.2.1. The High Cost of Drug Discovery Process
4.1.3. Opportunity
4.1.3.1. 3D-bioprinting to create advanced drug models
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. By Process Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
8.1.2. Market Attractiveness Index, By Process Type
8.2. Profiling & Lead Optimization*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Screening
8.4. Assay Development
8.5. Cell Engineering
8.6. Others
9. By Service Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
9.1.2. Market Attractiveness Index, By Service Type
9.2. Computational Chemistry*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Chemistry
9.4. ADME & DMPK
9.5. Biochemistry
9.6. Others
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Oncology*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurology
10.4. Metabolic & Inflammatory Disease
10.5. Immuno-Oncology
10.6. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical & Biotechnology companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Clinics
11.4. Academic Institutes
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. The U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. The U.K.
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. Company Profiles
14.1. Piramal Pharma Solutions*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Biopta
14.3. Charles River Laboratories International
14.4. Domainex
14.5. Evotec AG
14.6. Albany Molecular Research Inc.
14.7. GenScript
14.8. Pharmaceutical Product Development, LLC (PPD)
14.9. WuXi AppTec
14.10. Merck & Co., Inc.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

Piramal Pharma Solutions, 4.	Key Developments, Biopta, Charles River Laboratories International, Domainex, Evotec AG, Albany Molecular Research Inc., GenScript, Pharmaceutical Product Development, LLC (PPD), WuXi AppTec, Merck & Co., Inc.

표 목록 (Tables)

List of Tables Table 1 Global Drug Discovery Services Market Value, By Service Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Drug Discovery Services Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Drug Discovery Services Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Drug Discovery Services Market Value, By Service Type, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 6 Global Drug Discovery Services Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 8 Global Drug Discovery Services Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Drug Discovery Services Market Value, By Region, 2022-2033 (US$ Billion)

Table 10 North America Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 11 North America Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 12 North America Drug Discovery Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 13 Europe Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 14 Europe Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 15 Europe Drug Discovery Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 16 Asia-Pacific Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 17 Asia-Pacific Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 18 Asia-Pacific Drug Discovery Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 19 South America Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 20 South America Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 21 South America Drug Discovery Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 22 Middle East and Africa Drug Discovery Services Market Value, By Service Type, 2022-2033 (US$ Billion)

Table 23 Middle East and Africa Drug Discovery Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 24 Middle East and Africa Drug Discovery Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 Charles River Laboratories: Overview

Table 26 Charles River Laboratories: Product Portfolio

Table 27 Charles River Laboratories: Key Developments

Table 28 Thermo Fisher Scientific Inc.: Overview

Table 29 Thermo Fisher Scientific Inc.: Product Portfolio

Table 30 Thermo Fisher Scientific Inc.: Key Developments

Table 31 Labcorp: Overview

Table 32 Labcorp: Product Portfolio

Table 33 Labcorp: Key Developments

Table 34 WuXi AppTec: Overview

Table 35 WuXi AppTec: Product Portfolio

Table 36 WuXi AppTec: Key Developments

Table 37 Evotec: Overview

Table 38 Evotec: Product Portfolio

Table 39 Evotec: Key Developments

Table 40 Domainex: Overview

Table 41 Domainex: Product Portfolio

Table 42 Domainex: Key Developments

Table 43 GenScript: Overview

Table 44 GenScript: Product Portfolio

Table 45 GenScript: Key Developments

Table 46 Pharmaron: Overview

Table 47 Pharmaron: Product Portfolio

Table 48 Pharmaron: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 3 Global Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 4 Global Drug Discovery Services Market Share, By Region, 2024 & 2033 (%)

Figure 5 Global Drug Discovery Services Market Y-o-Y Growth, By Service Type, 2023-2033 (%)

Figure 6 Integrated Drug Discovery Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 7 Target Validation Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 8 Lead Optimization Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 9 Computational Chemistry Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 10 Medicinal Chemistry Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 11 ADME & DMPK Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 12 Biochemistry Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 13 Others Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 14 Global Drug Discovery Services Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 15 Oncology Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 16 Neurology Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 17 Metabolic Disorders Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 18 Inflammatory Disease Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 19 Immunology Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 20 Others Application in Global Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 21 Global Drug Discovery Services Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 22 North America Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 23 North America Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 24 North America Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 25 North America Drug Discovery Services Market Share, By Country, 2024 & 2033 (%)

Figure 26 Europe Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 27 Europe Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 28 Europe Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 29 Europe Drug Discovery Services Market Share, By Country, 2024 & 2033 (%)

Figure 30 Asia-Pacific Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 31 Asia-Pacific Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 32 Asia-Pacific Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 33 Asia-Pacific Drug Discovery Services Market Share, By Country, 2024 & 2033 (%)

Figure 34 South America Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 35 South America Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 36 South America Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 37 South America Drug Discovery Services Market Share, By Country, 2024 & 2033 (%)

Figure 38 Middle East and Africa Drug Discovery Services Market Value, 2022-2033 (US$ Billion)

Figure 39 Middle East and Africa Drug Discovery Services Market Share, By Service Type, 2024 & 2033 (%)

Figure 40 Middle East and Africa Drug Discovery Services Market Share, By Application, 2024 & 2033 (%)

Figure 41 Charles River Laboratories: Financials

Figure 42 Thermo Fisher Scientific Inc.: Financials

Figure 43 Labcorp: Financials

Figure 44 WuXi AppTec: Financials

Figure 45 Evotec: Financials

Figure 46 Domainex: Financials

Figure 47 GenScript: Financials

Figure 48 Pharmaron: Financials

글로벌 신약 개발 서비스 시장 – 2023-2030

Global Drug Discovery Services Market - 2023-2030